REVELAC-COVID-19 Generic Protocol (DRAFT)

Download (883.74 KB)

REVELAC-COVID-19 Generic protocol: Evaluation of the effectiveness of COVID-19 vaccines in Latin America and the Caribbean (DRAFT)

This document presents a generic protocol for evaluating the effectiveness of COVID-19 vaccines based on the sentinel surveillance strategy for severe acute respiratory infections (SARI), using existing regional platforms such as the Severe Acute Respiratory Infections Network (SARInet) and the Network for the Evaluation of Vaccine Effectiveness in Latin America and the Caribbean - influenza (REVELAC-i)